High therapy adherence but substantial limitations to daily activities amongst members of the Dutch inflammatory bowel disease patients' organization: a patient empowerment study
暂无分享,去创建一个
E. Kuipers | C. J. van der Woude | C. Looman | Z. Zelinková | P. Mensink | E. Kuipers | J. Baars | T. Markus | Z. Zelinkova | P. Mensink | P. B. F. MENSINK | C. W. N. LOOMAN | Zuzana Zelinkova | Peter Mensink | C. W. N. Looman | E. J. Kuipers | C. J. V. D. Woude
[1] Malte Kelm,et al. Clinical research for patient empowerment--a qualitative approach on the improvement of heart health promotion in chronic illness. , 2008, Medical science monitor : international medical journal of experimental and clinical research.
[2] G. Rubin,et al. Review article: medication non‐adherence in ulcerative colitis – strategies to improve adherence with mesalazine and other maintenance therapies , 2008, Alimentary pharmacology & therapeutics.
[3] Jan E. Irvine. Quality of life of patients with ulcerative colitis: Past, present, and future , 2008, Inflammatory bowel diseases.
[4] K. Mazzocco,et al. Risk factors for non‐adherence to medication in inflammatory bowel disease patients , 2007, Alimentary pharmacology & therapeutics.
[5] Michael P. Jones,et al. Quality of Life in Patients With Inflammatory Bowel Disease and Irritable Bowel Syndrome Differs Between Subjects Recruited from Clinic or the Internet , 2007, The American Journal of Gastroenterology.
[6] P. Lakatos,et al. Nonadherence in inflammatory bowel disease: Results of factor analysis , 2007, Inflammatory bowel diseases.
[7] E. Kuipers,et al. Adherence to gastroprotection and the risk of NSAID‐related upper gastrointestinal ulcers and haemorrhage , 2007, Alimentary pharmacology & therapeutics.
[8] M. Schwab,et al. Adherence to thiopurine treatment in out‐patients with Crohn’s disease , 2007, Alimentary pharmacology & therapeutics.
[9] L. Lix,et al. Predictors of Medication Adherence in Inflammatory Bowel Disease , 2007, The American Journal of Gastroenterology.
[10] W. D’hoore,et al. Patient empowerment in theory and practice: polysemy or cacophony? , 2007, Patient education and counseling.
[11] E. Cabré,et al. Medication-Taking Behavior in a Cohort of Patients with Inflammatory Bowel Disease , 2006, Digestive Diseases and Sciences.
[12] S. Dorn. Predictors of Crohn's disease. , 2006, Gastroenterology.
[13] C. Bernstein,et al. Health care resource utilization in inflammatory bowel disease. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[14] S. Kane. Systematic review: adherence issues in the treatment of ulcerative colitis , 2006, Alimentary pharmacology & therapeutics.
[15] K R Abrams,et al. Long‐term prognosis in Crohn's disease: factors that affect quality of life , 2006, Alimentary pharmacology & therapeutics.
[16] A. Lippman. Adherence to medication. , 2005, The New England journal of medicine.
[17] A. Francavilla,et al. A New Oral Delivery System for 5‐ASA: Preliminary Clinical Findings for MMX , 2005, Inflammatory bowel diseases.
[18] F. Casellas,et al. Impairment of Health‐Related Quality of Life in Patients With Inflammatory Bowel Disease: a Spanish Multicenter Study , 2005, Inflammatory bowel diseases.
[19] A. Román,et al. Adherence to treatment in inflammatory bowel disease. , 2005, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.
[20] S. Travis,et al. Guidelines for the management of inflammatory bowel disease in adults , 2004, Gut.
[21] M. J. Shale,et al. Studies of compliance with delayed‐release mesalazine therapy in patients with inflammatory bowel disease , 2003, Alimentary pharmacology & therapeutics.
[22] F. Carbonnel,et al. Long-Term Evolution of Disease Behavior of Crohn's Disease , 2002, Inflammatory bowel diseases.
[23] S. Hanauer,et al. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis , 2001, American Journal of Gastroenterology.
[24] F. Casellas,et al. Influence of inflammatory bowel disease on different dimensions of quality of life , 2001, European journal of gastroenterology & hepatology.
[25] S. Grosso,et al. Psychiatric Predictors of Noncompliance in Inflammatory Bowel Disease: Psychiatry and Compliance , 2001, Journal of clinical gastroenterology.
[26] C. Rand,et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. , 1999, Medical care.
[27] E. Lesaffre,et al. A frequency and correlation analysis of motor deficits in Parkinson patients. , 1998, Disability and rehabilitation.
[28] S. Hanauer,et al. An Oral Preparation of Mesalamine as Long-Term Maintenance Therapy for Ulcerative Colitis , 1996, Annals of Internal Medicine.
[29] P. Munkholm,et al. Course of ulcerative colitis: analysis of changes in disease activity over years. , 1994, Gastroenterology.
[30] S. Lo,et al. Oral mesalamine (Asacol) for mildly to moderately active ulcerative colitis. A multicenter study. , 1991, Annals of internal medicine.
[31] J. Paulley,et al. Reply , 1990, Gut.
[32] D. Sackett,et al. Can Simple Clinical Measurements Detect Patient Noncompliance? , 1980, Hypertension.
[33] A. Thomson. Patient nonadherence to medication in inflammatory bowel disease. , 2004, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[34] S. Hanauer,et al. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. , 2003, The American journal of medicine.